Navigation Links
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Date:6/17/2008

NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca on June 23, 2008.

HealthShares(TM) Autoimmune-Inflammation Index (HHA)

Drop

ACTIVE BIOTECH AB (OMX Nordic Exchange Stockholm: ACTI)

ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN)

COMBINATORX INC. (NASDAQ: CRXX)

DYNAVAX TECHNOLOGIES CORP (NASDAQ: DVAX)

ELAN CORP PLC-ADR (NYSE: ELN)

MEDAREX INC (NASDAQ: MEDX)

PHARMACOPEIA INC. (NASDAQ: ALXN)

ALKERMES INC. (NASDAQ: ALKS)

ALLERGAN INC. (NYSE: AGN)

ALLOS THERAPEUTICS INC. (NASDAQ: ALTH)

ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ALNY)

ALPHARMA INC. (NYSE: ALO)

ALTUS PHARMACEUTICALS INC. (NASDAQ: ALTU)

AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG)

ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)

APPLIED BIOSYSTEMS GROUP (NYSE: ABI)

ARK THERAPUTICS GROUP PLC (London Main Market, U.K.: AKT)

BASILEA PHARMACEUTICA-REG (Swiss Stock Exchange: BSLN)

BAVARIAN NORDIC A/S (OMX Nordic Exchange Copenhagen: BAVA)

BECKMAN COULTER INC. (NYSE: BEC)

BIOVAIL CORP (TSE: BVF)

BOSTON SCIENTIFIC CORP. (NYSE: BSX)

CARACO PHARMACEUTICAL LABS LTD (ASE: CPD)

CARDIOME PHARMA CORPORATION (TSE: CRME)

CRUCELL-ADR (NASDAQ: CRXL)

CUBIST PHARMACEUTICALS INC. (NASDAQ: CBST)

DENDREON CORP (NASDAQ: DNDN)

DENTSPLY INTERNATIONAL INC. (NASDAQ: XRAY)

DISCOVERY LABORATORIES INC. (NASDAQ: DSCO)

ENZO BIOCHEM INC. (NYSE: ENZ)

ENZON PHARMACEUTICALS INC. (NASDAQ: ENZN)

EXPRESS SCRIPTS INC. (NASDAQ: ESRX)

FLAMEL TECHNOLOGIES-ADR (NASDAQ: FLML)

GERON CORP (NASDAQ: GERN)

HEALTH NET INC. (NYSE: HNT)

ILLUMINA INC. (NASDAQ: ILMN)

INCYTE CORP. (NASDAQ: INCY)

INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ: IART)

INTUITIVE SURGICAL INC. (NASDAQ: ISRG)

KV PHARMACEUTICAL CO (NYSE: KV/A)

MASIMO CORPORATION (NASDAQ: MASI)

MEDA AB (OMX Nordic Exchange Stockholm: MEDAA)

OSI PHARMACEUTICALS INC (NASDAQ: OSIP)

SEPRACOR INC. (NASDAQ: SEPR)

SHIRE PLC-ADR (NASDAQ.: SHPGY)

SIGMA-ALDRICH (NASDAQ: SIAL)

WATERS CORP (NYSE: WAT)

Add

ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII)

AMERISOURCEBERGEN CORP (NYSE: ABC)

AUXILIUM PHARMACEUTICALS INC (NASDAQ: AUXL)

BIOMARIN PHARMACEUTICAL INC (NASDAQ: BMRN)

CARL ZEISS MEDITEC (Frankfurt, Germany: AFX)

CHUGAI PHARM CO (Tokyo SE: 4519)

CIGNA CORP (NYSE: CI)

COLOPLAST (OMX Nordic Exchange Copenhagen: COLOB)

CONMED CORP (NASDAQ: CNMD)

COUGAR BIOTECHNOLOGY INC (NASDAQ: CGRB)

COVANCE INC (NYSE: CVD)

DAINIPPON SUMITOMO (Tokyo SE: 4506)

EXELIXIS INC (NASDAQ: EXEL)

FRESENIUS SE (Frankfurt, Germany: FRE)

GEDEON RICHTER PLC (Budapest, Hungary: RICHTER)

GETINGE AB (OMX Nordic Exchange Stockholm: GETI B)

GRIFOLS SA (SIBE Spain: GRF)

H.LUNDBECK A/S (OMX Nordic Exchange Copenhagen: LUN)

HIKMA PHARMACEUTIC (London Main Market, U.K.: HIK)

HISAMITSU PHARM CO (Tokyo SE: 4530)

ISIS PHARMACEUTICALS INC (NASDAQ: ISIS)

KINETIC CONCEPTS INC (NYSE: KCI)

KISSEI PHARM CO (Tokyo SE: 4547)

KYOWA HAKKO KOGYO (Tokyo SE: 4151)

MEIJI SEIKA KAISHA (Tokyo SE: 2202)

MERCK KGAA (Frankfurt, Germany: MRK)

MORPHOSYS (Frankfurt, Germany: MOR)

MYRIAD GENETICS INC (NASDAQ: MYGN)

NICOX SA (Euronext, Paris: COX)

PATTERSON COS (NASDAQ: PDCO)

PHARMACEUTICAL PROD DEV INC (NASDAQ: PPDI)

PPG INDS INC (NYSE: PPG)

QUEST DIAGNOSTICS INC (NYSE: DGX)

SCHEIN HENRY INC (NASDAQ: HSIC)

SHIONOGI & CO (Tokyo SE: 4507)

STRAUMANN HLDG (SWX, Switzerland: STMN)

TELEFLEX INC (NYSE: TFX)

TORAY INDS INC (Tokyo SE: 3402)

TOYAMA CHEMICAL CO (Tokyo SE: 4518)

TRANSGENE (Euronext, Paris: TNG)

VALEANT PHARMACEUTICALS INTL (NYSE: VRX)

VERTEX PHARMACEUTICALS INC (NASDAQ: VRTX)

HealthShares(TM) Dermatology and Wound Care Index (HRW)

Drop

ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)

BARRIER THERAPEUTICS INC. (NASDAQ: BTRX)

INNOGENETICS NV (Euronext, Brussels: INNX)

INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ: IART)

KV PHARMACEUTICAL CO (NYSE: KV/A)

MEDIGENE AG (Frankfurt, Germany: MDG)

MENTOR CORP (NYSE: MNT)

MYLAN INC. (NYSE: MYL)

NUSKIN ENTERPRISES INC. (NYSE: NUS)

OMEGA PHARMA SA (Euronext, Brussels: OME)

PHOTOCURE ASA (Oslo, Norway: PHO)

QLT INC. (TSE: QLTI)

SINCLAIR PHARMA PLC (London Main Market, U.K.: SPH)

Add

ANGES MG INC (Tokyo SE: 4563)

APP PHARMACEUTICALS INC (NASDAQ: APPX)

ARPIDA AG (SWX, Switzerland: ARPN)

BTG (London Main Market, U.K.: BGC)

CYTOS BIOTECH AG (SWX, Switzerland: CYTN)

GENMAB AS (OMX Nordic Exchange Copenhagen: GEN)

NICOX SA (Euronext, Paris: COX)

PRESTIGE BRANDS HLDGS INC (NYSE: PBH)

Q-MED AB (OMX Nordic Exchange Stockholm: QMED)

SYNERON MEDICAL LTD (NASDAQ: ELOS)

TOPOTARGET A/S (OMX Nordic Exchange Copenhagen: TOPO)

TORAY INDS INC (Tokyo SE: 3402)

XOMA LTD (NASDAQ: XOMA)

HealthShares(TM) Diagnostics Index (HHD)

Drop

AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG)

ANALOGIC CORP. (NASDAQ: ALOG)

APPLERA CORP - CELERA GENOMICS (NASDAQ: CRA)

BIO-RAD LABORATORIES-CL A (ASE: BIO)

GIVEN IMAGING LTD (Tel Aviv, Israel: GIVNUQ)

HALOZYME THERAPUTICS INC. (NASDAQ: HALO)

MERIDIAN BIOSCIENCE INC. (NASDAQ: VIVO)

MERIT MEDICAL SYSTEMS INC. (NASDAQ: MMSI)

ORASURE TECHNOLOGIES INC (NASDAQ: PCOP)

RIGEL PHARMACEUTICALS INC. (NASDAQ: RIGL)

SEPRACOR INC. (NASDAQ: SEPR)

ZYMOGENETICS INC (NASDAQ: ZGEN)

Add

ALK-ABELLO A/S (OMX Nordic Exchange Copenhagen: ALK.B)

CHUGAI PHARM CO (Tokyo SE: 4519)

DR REDDYS LABS LTD (NYSE: RDY)

INCYTE CORP (NASDAQ: INCY)

LIFECYCLE PHARMA (OMX Nordic Exchange Copenhagen: LCP)

MYLAN INC (NYSE: MYL)

NABI BIOPHARMACEUTICALS (NASDAQ: OSUR)

QUIDEL CORP (NASDAQ: QDEL)

SONOSITE INC. (NASDAQ: SONO)

Add

BIOMERIEUX (Euronext, Paris: BIM)

CEPHEID (NASDAQ: CPHD)

DAINIPPON SUMITOMO (Tokyo SE: 4506)

GRIFOLS SA (SIBE Spain: GRF)

HAEMONETICS CORP (NYSE: HAE)

KYOWA HAKKO KOGYO (Tokyo SE: 4151)

MDS INC (NYSE: MDS)

MOOG INC (NYSE: MOG A)

NUVASIVE INC (NASDAQ: NUVA)

SHIONOGI & CO (Tokyo SE: 4507)

VARIAN INC (NASDAQ: VARI)

HealthShares(TM) Emerging Cancer Index (HHJ)

Drop

AETERNA ZENTARIS INC. (TSE: AEXS)

ALLOS THERAPEUTICS INC. (NASDAQ: ALTH)

ARQULE INC. (NASDAQ: ARQL)

ARRAY BIOPHARMA INC. (NASDAQ: ARRY)

BIOCRYST PHARMACEUTICALS INC. (NASDAQ: BCRX)

CELL GENESYS INC. (NASDAQ: CEGE)

DENDREON CORP (NASDAQ: DNDN)

DYNAVAX TECHNOLOGIES CORP (NASDAQ: DVAX)

GPC BIOTECH AG-ADR (NASDAQ: GPCB)

IMMUNOGEN INC. (NASDAQ: IMGN)

PEREGRINE PHARMACEUTICALS (NASDAQ: PPHM)

PROGENICS PHARMACEUTICALS (NASDAQ: PGNX)

TELIK INC. (NASDAQ: TELK)

XOMA LTD (NASDAQ: XOMA)

Add

ANTISOMA (London Main Market, U.K.: ASM)

ARDEA BIOSCIENCES INC (NASDAQ: RDEA)

BAVARIAN NORDIC (OMX Nordic Exchange Copenhagen: BAVA)

BTG (London Main Market, U.K.: BGC)

COUGAR BIOTECHNOLOGY INC (NASDAQ: CGRB)

EXELIXIS INC (NASDAQ: EXEL)

LIGAND PHARMACEUTICALS INC (NASDAQ: LGND)

MAXYGEN INC (NASDAQ: MAXY)

MOLECULAR INSIGHT PHARM INC (NASDAQ: MIPI)

MORPHOSYS (Frankfurt, Germany: MOR)

NEKTAR THERAPEUTICS (NASDAQ: NKTR)

PROTHERICS (London Main Market, U.K.: PTI)

TOPOTARGET A/S (OMX Nordic Exchange Copenhagen: TOPO)

TRANSGENE (Euronext, Paris: TNG)

HealthShares(TM) Enabling Technologies Index (HHV)

Drop

ACCELRYS INC. (NASDAQ: ACCL O)

AFFYMETRIX INC. (NASDAQ: AFFX)

APPLIED BIOSYSTEMS GROUP (NYSE: ABI)

BECKMAN COULTER INC. (NYSE: BEC)

CAMBREX CORP (NYSE: CBM)

CEPHEID INC. (NASDAQ: CPHD)

EURAND NV (NASDAQ: EURX)

HUMAN GENOME SCIENCES INC. (NASDAQ: HGSI)

LUMINEX CORP (NASDAQ: LMNX)

MILLIPORE CORP (NYSE: MIL)

PERKINELMER INC. (NYSE: PKI)

QIAGEN N.V. (NASDAQ: QGEN)

QUEST DIAGNOSTICS (NYSE: DGX)

SANGAMO BIOSCIENCES INC. (NASDAQ: SGMO)

SIGMA-ALDRICH (NASDAQ: SIAL)

SYMYX TECHNOLOGIES INC. (NASDAQ: SMMX)

TECHNE CORP (NASDAQ: TECH)

WATERS CORP (NYSE: WAT)

Add

ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII)

ALKERMES INC (NASDAQ: ALKS)

AMERISOURCEBERGEN CORP (NYSE: ABC)

APP PHARMACEUTICALS INC (NASDAQ: APPX)

CEPHALON INC (NASDAQ: CEPH)

CHARLES RIV LABS INTL INC (NYSE: CRL)

COVANCE INC (NYSE: CVD)

ENDO PHARMACEUTICALS HLDGS INC (NASDAQ: ENDP)

HOSPIRA INC (NYSE: HSP)

INVENTIV HEALTH INC (NASDAQ: VTIV)

OMNICARE INC (NYSE: OCR)

PAREXEL INTL CORP (NASDAQ: PRXL)

PHARMACEUTICAL PROD DEV INC (NASDAQ: PPDI)

PSS WORLD MED INC (NASDAQ: PSSI)

VARIAN MED SYS INC (NYSE: VAR)

WATSON PHARMACEUTICALS INC (NYSE: WPI)

WEST PHARMACEUTICAL SVSC INC (NYSE: WST)

XENOPORT INC (NASDAQ: XNPT)

HealthShares(TM) European Drugs Index (HRJ)

Drop

ACTELION LTD-REG (Virt-X, Switzerland: ATLN)

BASILEA PHARMACEUTICA-REG (SWX, Switzerland: BSLN)

BAVARIAN NORDIC A/S (OMX Nordic Exchange Copenhagen: BAVA)

CRUCELL-ADR (NASDAQ: CRXL)

CYTOS BIOTECHNOLOGY AG-REG (SWX, Switzerland: CYTN)

ELAN CORP PLC-ADR (NYSE: ELN)

FAES FARMA SA (SIBE Spain: FAE)

GPC BIOTECH AG (NASDAQ: GPC)

GRIFOLS SA (SIBE Spain: GRF)

H LUNDBECK A/S (OMX Nordic Exchange Copenhagen: LUN)

INTERCELL AG (Wiener Bourse, Austria: ICLL)

RICHTER GEDEON NYRT (Budapest, Hungary: RICHTBO)

STADA ARZNEIMITTEL AG (Frankfurt, Germany: SAZ)

ZELTIA SA (SIBE Spain: ZEL)

Add

COLOPLAST (OMX Nordic Exchange Copenhagen: COLOB)

EGIS PHARMACEUTICA (Budapest, Hungary: EGIS)

FRESENIUS SE (Frankfurt, Germany: FRE)

GALENICA AG (SWX, Switzerland: GALN)

MERCK KGAA (Frankfurt, Germany: MRK)

MORPHOSYS (Frankfurt, Germany: MOR)

NEUROSEARCH A/S (OMX Nordic Exchange Copenhagen: NEUR)

ORION CORPORATION (OMX Nordic Exchange Helsinki: ORNAV)

PRONOVA BIOPHARMA (Oslo, Norway: PRON)

Q-MED AB (OMX Nordic Exchange Stockholm: QMED)

SPEEDEL HLDG AG (SWX, Switzerland: SPPN)

STALLERGENES (Euronext, Paris: GENP)

TRANSGENE (Euronext, Paris: TNG)

UCB (Euronext, Brussels: UCB)

HealthShares(TM) European Medical Products & Devices Index (HHT)

Drop

CONSORT MEDICAL PLC (London Main=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >NABI)

REGENERON PHARMACEUTICALS (NASDAQ: REGN)

STALLERGENES (Euronext, Paris: GENP)

UCB (Euronext, Brussels: UCB)

HealthShares(TM) Cancer Index (HHK)

Drop

ARK THERAPUTICS GROUP PLC (London Main Market, U.K.: AKT)

EXELIXIS INC. (NASDAQ: EXEL)

HUMAN GENOME SCIENCES INC. (NASDAQ: HGSI)

MEDAREX INC (NASDAQ: MEDX)

SEATTLE GENETICS INC (NASDAQ: SGEN)

SYNTA PHARMACEUTICALS CORP (NASDAQ: SNTA)

ZYMOGENETICS INC (NASDAQ: RDY)

EISAI CO LTD (Tokyo SE: 4523)

INDEVUS PHARMACEUTICALS INC. (NASDAQ: IDEV)

MENTOR CORP (NYSE: MNT)

GEDEON RICHTER NYRT (Budapest, Hungary: RICHTER)

SOLVAY SA (Euronext, Brussels: SOLB)

UCB SA (Euronext, Brussels: UCB)

Add

ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII)

ALTUS PHARMACEUTICALS INC (NASDAQ: ALTU)

GTX INC (NASDAQ: GTXI)

HOLOGIC INC (NASDAQ: HOLX)

PAR PHARMACEUTICAL COS INC (NYSE: PRX)

SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP)

VALEANT PHARMACEUTICALS INTL (NYSE: VRX)

XENOPORT INC (NASDAQ: XNPT)

HealthShares(TM) Infectious Disease Index (HHG)

Drop

ENZO BIOCHEM INC. (NYSE: ENZ)

FLAMEL TECHNOLOGIES-ADR (NASDAQ: FLML)

HUMAN GENOME SCIENCES INC. (NASDAQ: HGSI)

IDENIX PHARMACEUTICALS INC. (NASDAQ: IDIX)

INNOGENETICS NV (Euronext, Brussels: INNX)

KING PHARMACEUTICALS INC. (NYSE: KG)

MEDAREX INC (NASDAQ: MEDX)

SOLVAY SA (Euronext, Brussels: SOLB)

THERAVANCE INC. (NASDAQ: THRX)

Add

DR REDDYS LABS LTD (NYSE: RDY)

HIKMA PHARMACEUTIC (London Main Market, U.K.: HIK)

KUREHA CORPORATION (Tokyo SE: 4023)

MEIJI SEIKA KAISHA (Tokyo SE: 2202)

MYRIAD GENETICS INC (NASDAQ: MYGN)

PAR PHARMACEUTICAL COS INC (NYSE: PRX)

PHARMASSET INC (NASDAQ: VRUS)

SHIONOGI & CO (Tokyo SE: 4507)

TOYAMA CHEMICAL CO (Tokyo SE: 4518)

HealthShares(TM) Metabolic-Endocrine Disorders Index (HHM)

Drop

AMICUS THERAPUTICS INC. (NASDAQ: FOLD)

COMBINATORX INC. (NASDAQ: CRXX)

GW PHARMACEUTICALS PLC (London Main Market, U.K.: GWP)

INCYTE CORP. (NASDAQ: ZGEN)

Add

ABRAXIS BIOSCIENCE INC (NASDAQ: ABII)

CHUGAI PHARM CO (Tokyo SE: 4519)

DR REDDYS LABS LTD (NYSE: RDY)

GENMAB AS (OMX Nordic Exchange Copenhagen: GEN)

KYOWA HAKKO KOGYO (Tokyo SE: 4151)

MERCK KGAA (Frankfurt, Germany: MRK)

YAKULT HONSHA CO (Tokyo SE: 2267)

HealthShares(TM) Cardio Devices Index (HHE)

Drop

ANGIODYNAMICS INC. (NASDAQ: ANGO)

ATRION CORPORATION (NASDAQ: ATRI)

BOSTON SCIENTIFIC CORP. (NYSE: BSX)

CARDIAC SCIENCE CORP (NASDAQ: CSCX)

CRYOLIFE INC. (NYSE: CRY)

ENDOLOGIX INC. (NASDAQ: ELGX)

INTUITIVE SURGICAL INC. (NASDAQ: ISRG)

KENSEY NASH CORP (NASDAQ: KNSY)

SPECTRANETICS CORP (NASDAQ: SPNC)

STEREOTAXIS INC. (NASDAQ: STXS)

VASCULAR SOLUTIONS INC. (NASDAQ: VASC)

Add

CONMED CORP (NASDAQ: CNMD)

GREATBATCH INC (NYSE: GB)

HOSPIRA INC (NYSE: HSP)

KINETIC CONCEPTS INC (NYSE: KCI)

OSI SYSTEMS INC (NASDAQ: OSIS)

PALL CORP (NYSE: PLL)

RTI BIOLOGICS INC (NASDAQ: RTIX)

SONOSITE INC (NASDAQ: SONO)

TELEFLEX INC (NYSE: TFX)

UNITED THERAPEUTICS CORP DEL (NASDAQ: UTHR)

VITAL SIGNS INC (NASDAQ: VITL)

HealthShares(TM) Cardiology Index (HRD)

Drop

ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN)

AMYLIN PHARMACEUTICALS INC. (NASDAQ: AMLN)

ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)

CARDIOME PHARMA CORPORATION (TSE: CRME)

CV THERAPEUTICS INC. (NASDAQ: CVTX)

EDWARDS LIFESCIENCES CORP (NYSE: EW)

MEDICINES COMPANY (NASDAQ: MDCO)

MOMENTA PHARMACEUTICALS INC (NASDAQ: MNTA)

NUVELO INC (NASDAQ: NUVO)

PAR PHARMACEUTICAL COS INC. (NYSE: PRX)

SANGAMO BIOSCIENCES INC. (NASDAQ: SGMO)

SCIELE PHARMA INC. (NASDAQ: SCRX)

SPEEDEL HOLDING AG-REG (SWX, Switzerland: SPPN)

Add

ABRAXIS BIOSCIENCE INC (NASDAQ: ABII)

BIOMARIN PHARMACEUTICAL INC (NASDAQ: BMRN)

DAINIPPON SUMITOMO (Tokyo SE: 4506)

DR REDDYS LABS LTD (NYSE: RDY)

EISAI CO (Tokyo SE: 4523)

ISIS PHARMACEUTICALS INC (NASDAQ: ISIS)

NISSAN CHEMICAL INC (Tokyo SE: 4021)

PRONOVA BIOPHARMA (Oslo, Norway: PRON)

RECORDATI (Borsa Italiana MTA: REC)

REGENERON PHARMACEUTICALS (NASDAQ: REGN)

TORAY INDS INC (Tokyo SE: 3402)

TOYOBO CO (Tokyo SE: 3101)

VALEANT PHARMACEUTICALS INTL (NYSE: VRX)

HealthShares(TM) Composite Index (HHQ)

Drop

ADOLOR CORPORATION (NASDAQ: ADLR)

ALEXION PHARMACEUTICALS INC. (NASDAQ:

SOURCE Mergent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Spectra BioPharma Selling Solutions (Spectra) is a new ... the experience, expertise, operational delivery and customer focus ... Created in concert with industry leading commercial experts, ... tactical needs of its clients by providing value-based ... and non-personal promotion. --> ...
(Date:2/11/2016)... Feb. 11, 2016   BioInformant announces the ... Cell Research Products, Opportunities, Tools, and Technologies – Market ... The first ... stem cell industry, BioInformant has more than a decade ... cell market, by stem cell type. This powerful 175 ...
(Date:2/10/2016)... 2016 Early-career researchers from ... , Uganda and Yemen ... and nutrition   Indonesia , Nepal ... and Yemen are being honored for their accomplishments ... also celebrated for mentoring young women scientists who are pursuing careers in ...
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
Breaking Biology Technology:
(Date:2/8/2016)... , February 8, 2016 ... platform which presents innovation for clients, comfort and ... called VoiceKey. --> Worldcore is ... innovation for clients, comfort and unbeatable security, with ... --> Worldcore is the first ...
(Date:2/3/2016)... , February 3, 2016 ... new market research report "Automated Fingerprint Identification System Market ... Latent Search), Application (Banking & Finance, Government, Healthcare, and ... by MarketsandMarkets, the market is expected to be worth ... of 21.0% between 2015 and 2020. The transformation and ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
Breaking Biology News(10 mins):